UBS Group’s Matinas BioPharma MTNB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $98 | Sell |
110
-1,530
| -93% | -$1.36K | ﹤0.01% | 8681 |
|
|
2025
Q1 | $853 | Sell |
1,640
-10,673
| -87% | -$5.55K | ﹤0.01% | 8322 |
|
|
2024
Q4 | $6.28K | Buy |
12,313
+8,886
| +259% | +$4.53K | ﹤0.01% | 7334 |
|
|
2024
Q3 | $12.1K | Buy |
+3,427
| New | +$12.1K | ﹤0.01% | 6437 |
|
|
2024
Q2 | – | Sell |
-898
| Closed | -$12.2K | – | 8625 |
|
|
2024
Q1 | $12.2K | Buy |
+898
| New | +$12.2K | ﹤0.01% | 5977 |
|
|
2023
Q3 | – | Sell |
-286
| Closed | -$5.15K | – | 8554 |
|
|
2023
Q2 | $5.15K | Buy |
+286
| New | +$5.15K | ﹤0.01% | 6388 |
|
|
2023
Q1 | – | Sell |
-237
| Closed | -$5.93K | – | 8814 |
|
|
2022
Q4 | $5.93K | Buy |
+237
| New | +$5.93K | ﹤0.01% | 7912 |
|
|
2021
Q4 | – | Sell |
-206
| Closed | -$13K | – | 9288 |
|
|
2021
Q3 | $13K | Buy |
206
+155
| +304% | +$9.78K | ﹤0.01% | 6533 |
|
|
2021
Q2 | $2K | Sell |
51
-299
| -85% | -$11.7K | ﹤0.01% | 7850 |
|
|
2021
Q1 | $18K | Buy |
350
+316
| +929% | +$16.3K | ﹤0.01% | 6446 |
|
|
2020
Q4 | $2K | Sell |
34
-2,830
| -99% | -$166K | ﹤0.01% | 7073 |
|
|
2020
Q3 | $110K | Buy |
2,864
+657
| +30% | +$25.2K | ﹤0.01% | 4301 |
|
|
2020
Q2 | $85K | Buy |
2,207
+2,042
| +1,238% | +$78.6K | ﹤0.01% | 4603 |
|
|
2020
Q1 | $5K | Buy |
165
+93
| +129% | +$2.82K | ﹤0.01% | 6380 |
|
|
2019
Q4 | $8K | Buy |
+72
| New | +$8K | ﹤0.01% | 6315 |
|
|
2019
Q2 | – | Sell |
-216
| Closed | -$12K | – | 7072 |
|
|
2019
Q1 | $12K | Sell |
216
-252
| -54% | -$14K | ﹤0.01% | 5851 |
|
|
2018
Q4 | $14K | Buy |
+468
| New | +$14K | ﹤0.01% | 6119 |
|
|
2018
Q3 | – | Sell |
-88
| Closed | -$2K | – | 7111 |
|
|
2018
Q2 | $2K | Buy |
+88
| New | +$2K | ﹤0.01% | 6797 |
|
|
2018
Q1 | – | Sell |
-219
| Closed | -$13K | – | 6994 |
|
|
2017
Q4 | $13K | Buy |
219
+96
| +78% | +$5.7K | ﹤0.01% | 5897 |
|
|
2017
Q3 | $9K | Sell |
123
-653
| -84% | -$47.8K | ﹤0.01% | 6035 |
|
|
2017
Q2 | $66K | Buy |
776
+706
| +1,009% | +$60K | ﹤0.01% | 4559 |
|
|
2017
Q1 | $10K | Buy |
+70
| New | +$10K | ﹤0.01% | 5689 |
|